Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2008
11/18/2008CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/18/2008CA2375743C Methods and compositions for the support, regeneration and repair of connective tissues
11/18/2008CA2362281C Combinations for the treatment of diseases involving angiogenesis
11/18/2008CA2358054C Cyanocobalamin (vitamin b12) treatment in allergic disease
11/18/2008CA2352946C Baby food stimulating growth of the thymus
11/18/2008CA2326809C Solid, quick dissolving cetirizine formulations
11/18/2008CA2316298C Fat blend
11/18/2008CA2298349C Antiallergic composition and antipruritic composition
11/18/2008CA2210491C Antagonists of interleukin-15
11/18/2008CA2193993C New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
11/18/2008CA2172376C Antibodies to cd40
11/18/2008CA2156495C Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells
11/18/2008CA2124161C Pharmaceuticals for treating sepsis and septic shock
11/18/2008CA1341585C Recombinant retroviruses
11/13/2008WO2008137915A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/13/2008WO2008137794A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors
11/13/2008WO2008137770A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors
11/13/2008WO2008137118A1 Suppression of inflammation associated with transplantation using an epsilon pkc inhibitor
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008136736A2 Immunoregulatory structures from normally occurring proteins
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008135791A1 Imidazoquinolines with immuno-modulating properties
11/13/2008WO2008135419A2 Anti-il-6-agents for improving primary functioning of allogenic grafts
11/13/2008WO2008134879A1 Il-12 immunotherapy for cancer
11/13/2008WO2008134878A1 Compositions and methods for cancer treatment
11/13/2008WO2008134876A1 Cancerous disease modifying antibodies
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008115098A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
11/13/2008WO2008100620A3 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
11/13/2008WO2008081331A3 Enhancing the level of antibody expression by framework re-engineering
11/13/2008WO2008079030A8 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
11/13/2008WO2008068638A3 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
11/13/2008WO2008022189A3 Administration of high potency platinum compound formulations by inhalation
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008US20080280934 Porphyrin ring compound containing cyanovinyl group; reacted with Vilsmeier reagent,complexed with metal ion in prsence of an acid and oxidizer; skin disorders; antiinflammatory agents; anticancer agents; antitumor agents; vascular disorders, vision defects, urogenital system disorders; immunology
11/13/2008US20080280932 Synergistic mixture of inosine monophosphate dehydrogenasr inhibitor and hydroxy-3-methylglutaryl coenzyme a reductase inhibitor; low dosage; transplant rejection therapy, atherosclerosis, cardiovascular disorders, lupus, irritable bowel disorders, Crohn'd disease, antidiabetic agents, rheumatic diseases
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280876 Sphingosine-1-phosphate (S1P) receptor agonists or antagonists; immunosuppressants; e.g. 3-(3-chloro-4-isopropoxyphenyl)-5-(p-(3-carboxyazetidin-1-ylmethyl)phenyl)-1,2,4-oxadiazole; two specific compounds are excluded
11/13/2008US20080280869 Therapy for diseases resulting from mutation of messenger Rna; suppression prenature translation termination; autoimmune diseases; blood disorders; collagen disease; diabetes; neurodegenerative diseases; cardiovascular disorders; central nervous system disorders; antiinflammatory agents
11/13/2008US20080280868 Pyridine Derivatives and Their Use as Cb2 Receptor Modulators
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280859 Gemini vitamin d3 compounds and methods of use thereof
11/13/2008US20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods
11/13/2008US20080280852 Composition Containing Fermentable Polysaccharides
11/13/2008US20080280828 Compositions Comprising Igbpma and Uses Thereof
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279958 Snake venom compositions and methods of use
11/13/2008US20080279934 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis
11/13/2008US20080279890 Viral antigens
11/13/2008US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug.
11/13/2008US20080279886 recombinant virus that substantially lacks a phosphoprotein gene that is not required for growth of the virus in cultured cells but is important for establishing a latent infection
11/13/2008US20080279877 Human papilloma viral (HPV) thermostable fusion for use in developing vaccine for infection prevention; cervical cancer treatment
11/13/2008US20080279874 Compositions and methods for modulation of plk1 kinase activity
11/13/2008US20080279867 Prevent trabsplant rejection; autoimmune diseases
11/13/2008US20080279866 Treating lymphomas, allergies and autoimmune diseases via apoptotic induction; using ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933) and lymphocyte specific immunoglobulins
11/13/2008US20080279863 Using polyclonal goose antibodies as therapeutic tool in preventing viral infection of birds and mammals
11/13/2008US20080279862 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders
11/13/2008US20080279861 Method for stimulating a host immune system by administering an allogeneic cell material
11/13/2008US20080279854 Tumor suppressor antigen (5T4) for use as therapeutic tool in treatment and prevention of cell proliferative disorders
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279851 Type I transmembrane protein specific immunoglobulin for treatment and prevention of cell proliferative and inflammatory disorders
11/13/2008US20080279850 Tetraspanin specific immunoglobulin for use in the treatment and prevention of non-burkitt's malignancy
11/13/2008US20080279848 Using mixture comprising cluster of differentiation-4 (CD4) specific immunoglobulin and/or cyclophosphamide, mycophenolate mofetil and/or CTLA4-Ig to treat and prevent autoimmune, skin, inflammatory and respiratory system disorders
11/13/2008US20080279840 Treating vision and skin disorders with amine oxidase therapeutics
11/13/2008US20080279829 Phenyl-(4-Phenyl-Pyrimidin-2-Yl)-Amines For Enhancing Immunotolerance
11/13/2008US20080279826 Propagating lymphocytes in presence of rapamycin, transplanting in to mammals, monitoring graft rejection; immunosuppression; immunotherapy
11/13/2008US20080279819 Therapeutic mixture comprising uncompetitive n-methylaspartic acid receptor antagonist, glatiramer acetate and monoclonal antibody for use in treatment of multiple sclerosis
11/13/2008US20080279817 Treatment of Autoimmune Diseases and Allograft Rejection with IL-21
11/13/2008US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders
11/13/2008US20080279812 Disease Prevention and Vaccination Prior to Thymic Reactivation
11/13/2008CA2723320A1 Il-12 immunotherapy for cancer
11/13/2008CA2686382A1 Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
11/13/2008CA2686379A1 Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors
11/13/2008CA2686163A1 Imidazoquinolines with immuno-modulating properties
11/13/2008CA2685215A1 Compounds and methods useful for treating asthma and allergic inflammation
11/13/2008CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008CA2684906A1 Cancerous disease modifying antibodies
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990410A1 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990055A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1988896A2 Immune response modifier conjugates
11/12/2008EP1988890A1 High dosage of mycophenolic acid (mpa)
11/12/2008EP1988882A2 Prolongation of survival of an allograft by inhibiting complement activity
11/12/2008EP1988879A1 Pro-nanodispersion for the delivery of cyclosporin
11/12/2008EP1863474B1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
11/12/2008EP1561759B1 Cell death-inducing agent
11/12/2008EP1549648B1 Bicyclic heteroaromatic compounds as kinase inhibitors
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 1172